Tarveda Therapeutics
Philip Kantoff is on the Board of Advisors at Tarveda Therapeutics. Philip is also a Nancy and Jerome Kohlberg Professor of Medicine at Harvard Medical School.
This person is not in the org chart
This person is not in any offices
Tarveda Therapeutics
Tarveda Therapeutics is a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, for the treatment of patients with various solid tumor malignancies.